Brenntag partners with Shinehigh to deliver advanced supramolecular technology to global beauty and personal care markets

Brenntag partners with Shinehigh to deliver advanced supramolecular technology to global beauty and personal care markets

(IN BRIEF) Brenntag has signed an exclusive global distribution agreement with Shinehigh to deliver advanced supramolecular active ingredient technologies to the beauty and personal care market. The partnership covers key regions including Europe, North America, and Asia, and focuses on enhancing product performance through improved ingredient stability, penetration, and efficacy. By combining Shinehigh’s molecular engineering expertise with Brenntag’s global distribution capabilities, the collaboration aims to support the development of high-performance, science-driven formulations. The agreement reflects growing demand for innovative and effective solutions in the beauty industry.

(PRESS RELEASE) ESSEN, 27-Apr-2026 — /EuropaWire/ — Brenntag SE has entered into an exclusive global distribution agreement with Shinehigh to bring advanced supramolecular active ingredient technologies to the beauty and personal care sector.

Under the terms of the agreement, Brenntag Specialties will act as the exclusive distribution partner for Shinehigh’s innovative supramolecular technology across multiple regions, including Europe (excluding Russia), North America, Brazil, Colombia, India, and Vietnam. The collaboration is designed to expand access to next-generation functional ingredients that enhance product performance in skincare and haircare applications.

Shinehigh’s proprietary technology platform focuses on molecular-level engineering through its Supramolecular AI R&D Center. This approach enables the precise design and optimization of active ingredients, improving their stability, penetration, and synergistic performance. The result is enhanced efficacy in addressing key consumer needs such as hydration, anti-aging, and skin radiance.

Through this partnership, Brenntag aims to strengthen its portfolio of high-performance specialty ingredients by incorporating scientifically validated actives supported by both in vivo and in vitro testing. These technologies are expected to support the development of more effective and innovative formulations within the fast-growing global beauty and personal care market.

Teresa Harding, Senior Director Strategic Marketing & Innovation for Beauty & Care at Brenntag Specialties, highlighted the complementary strengths of the two companies. She emphasized that the collaboration combines Shinehigh’s expertise in supramolecular science with Brenntag’s global distribution network and local innovation capabilities, enabling customers to create products that meet increasing demand for science-driven performance.

Jiaheng Zhang, founder of Shinehigh, noted that the partnership aligns with both companies’ shared vision of advancing innovation in the industry. He pointed out that leveraging Brenntag’s market reach will help unlock the full potential of Shinehigh’s technologies and deliver high-performance solutions to customers worldwide.

Shinehigh’s research is built on its Synthrix™ AI supramolecular R&D platform, which supports precise molecular design and rapid screening of new materials. The company has developed multiple proprietary technology systems aimed at overcoming common challenges associated with traditional active ingredients, such as limited penetration, instability, and insufficient synergy.

With applications extending beyond beauty and personal care into sectors such as food additives and new energy, Shinehigh continues to expand its technological footprint. The partnership with Brenntag represents a strategic step in bringing these innovations to a broader global audience.

About Shinehigh:
Shinehigh is a world-leading supramolecular material technology enterprise dedicated to advancing research in materials science. With its Supramolecular Intelligent Self-Assembly Platform as its core technological foundation, the company has established six original technology systems to overcome industry pain points such as poor penetration, instability, and weak synergy of traditional active ingredients. Leveraging its self-developed Synthrix™ AI Supramolecular R&D Platform, Shinehigh achieves precision molecular design and high-throughput screening. Currently, Shinehigh’s research breakthroughs span across food additives, beauty and personal care, and new energy sectors, providing the beauty and personal care industry with high-penetration, high-efficacy, and high-stability specialty active ingredient solutions.

About Brenntag:
Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 17,300 employees worldwide and operates a network of around 600 sites in more than 70 countries. In 2025, Brenntag generated sales of 15.2 billion EUR. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a diversified and broad portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries. Brenntag pursues an ambitious sustainability agenda and is committed to sustainable solutions in its own sector and the industries served. Brenntag shares have been listed at the Frankfurt Stock Exchange since 2010, in the DAX since September 2021. In addition, the Brenntag SE shares are listed in the DAX 30 ESG and DAX ESG Target. For more information, visit www.brenntag.com.

Media Contacts:

Robert Reitze
Brenntag SE
Global Communications
Telephone: +49 (201) 6469-2128
global.comminications@brenntag.com

www.brenntag.com

SOURCE: Brenntag SE